BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. ✅
Go to Publication ✅
PeerJ (PeerJ ) Vol: 1 Issue Pages: e32 Pub: 2013 Epub: 2013 Feb 26 Authors Lahti L , Salonen A , Kekkonen RA , Salojärvi J , Jalanka-Tuovinen J , Palva A , Orešic M , de Vos WM , |
|
|
Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg-deficiency. ✅
Go to Publication ✅
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2021 Mar 31 Epub: 2021 Mar 31 Authors Liu Y , Hoang TK , Taylor CM , Park ES , Freeborn J , Luo M , Roos S , Rhoads JM , |
|
|
Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 9 Issue 1 Pages: 61-70 Pub: 2018 Jan 29 Epub: 2017 Oct 25 Authors Lau AS , Yanagisawa N , Hor YY , Lew LC , Ong JS , Chuah LO , Lee YY , Choi SB , Rashid F , Wahid N , Sugahara H , Xiao JZ , Liong MT , |
|
|
Characterization of feline-originated probiotics Lactobacillus rhamnosus CACC612 and Bifidobacterium animalis subsp. lactis CACC789 and and evaluation of their host response. ✅
Go to Publication ✅
BMC veterinary research (BMC Vet Res ) Vol: 20 Issue 1 Pages: 128 Pub: 2024 Apr 1 Epub: 2024 Apr 1 Authors Jang HJ , Kim JA , Kim Y , |
|
|
Changes in the gut microbiota composition of healthy young volunteers after administration of Lacticaseibacillus rhamnosus LRa05: A placebo-controlled study. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1105694 Pub: 2023 Epub: 2023 Mar 14 Authors Gai Z , Dong Y , Xu F , Zhang J , Yang Y , Wang Y , |
|
|
Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1081778 Pub: 2022 Epub: 2023 Jan 5 Authors Han M , Liao W , Dong Y , Bai C , Gai Z , |
|
|
Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1081778 Pub: 2022 Epub: 2023 Jan 5 Authors Han M , Liao W , Dong Y , Bai C , Gai Z , |
|
|
Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1?3)-ß-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 5 Pages: Pub: 2022 Feb 24 Epub: 2022 Feb 24 Authors Tungsanga S , Panpetch W , Bhunyakarnjanarat T , Udompornpitak K , Katavetin P , Chancharoenthana W , Chatthanathon P , Somboonna N , Tungsanga K , Tumwasorn S , Leelahavanichkul A , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus TR08 Improves Dyslipidemia in Mice Fed with a High Fat Diet by Regulating the Intestinal Microbiota, Reducing Systemic Inflammatory Response, and Promoting Sphingomholipid Metabolism. ✅
Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 21 Pages: Pub: 2022 Oct 29 Epub: 2022 Oct 29 Authors Feng X , Ding L , Ma G , Zhang Y , Sun Y , Li Z , Tao X , Ali A , Wang D , Wu L , |
|
|
Elucidation of Anti-Hypertensive Mechanism by a Novel Lactobacillus rhamnosus AC1 Fermented Soymilk in the Deoxycorticosterone Acetate-Salt Hypertensive Rats. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 15 Pages: Pub: 2022 Aug 2 Epub: 2022 Aug 2 Authors Wu H , Jiang L , Shum TF , Chiou J , |
|
|
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 772532 Pub: 2021 Epub: 2021 Dec 14 Authors Gao G , Ma T , Zhang T , Jin H , Li Y , Kwok LY , Zhang H , Sun Z , |
|
|
Lactobacillus rhamnosus LB1 Alleviates Enterotoxigenic Escherichia coli-Induced Adverse Effects in Piglets by Improving Host Immune Response and Anti-Oxidation Stress and Restoring Intestinal Integrity. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 724401 Pub: 2021 Epub: 2021 Nov 2 Authors Wu T , Shi Y , Zhang Y , Zhang M , Zhang L , Ma Z , Zhao D , Wang L , Yu H , Hou Y , Gong J , |
|
|
Lactobacillus rhamnosus LRa05 Ameliorate Hyperglycemia through a Regulating Glucagon-Mediated Signaling Pathway and Gut Microbiota in Type 2 Diabetic Mice. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 31 Pages: 8797-8806 Pub: 2021 Aug 11 Epub: 2021 Aug 2 Authors Wu T , Zhang Y , Li W , Zhao Y , Long H , Muhindo EM , Liu R , Sui W , Li Q , Zhang M , |
|
|
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , |
|
|
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , |
|
|
Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 22384 Pub: 2024 Sep 27 Epub: 2024 Sep 27 Authors Kwon H , Nam EH , Kim H , Jo H , Bang WY , Lee M , Shin H , Kim D , Kim J , Kim H , Lee J , Jung YH , Yang J , Won DD , Shin M , |
|
|
Characterization of the probiotic properties of Lacticaseibacillus rhamnosus LR6 isolated from the vaginas of healthy Korean women against vaginal pathogens. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1308293 Pub: 2023 Epub: 2023 Nov 30 Authors Chung Y , Kang SB , Son D , Lee JY , Chung MJ , Lim S , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Stachyose in combination with L. rhamnosus GG ameliorates acute hypobaric hypoxia-induced intestinal barrier dysfunction through alleviating inflammatory response and oxidative stress. ✅
Go to Publication ✅
Free radical biology & medicine (Free Radic Biol Med ) Vol: 212 Issue Pages: 505-519 Pub: 2024 Feb 20 Epub: 2024 Jan 9 Authors Ren D , Ding M , Su J , Ye J , He X , Zhang Y , Shang X , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
